Becton Dickinson & Co (NYSE: BDX) on Tuesday, soared 1.88% from the previous trading day, before settling in for the closing price of $227.83. Within the past 52 weeks, BDX’s price has moved between $218.75 and $251.99.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 4.72%. The company achieved an average annual earnings per share of 9.72%. With a float of $286.60 million, this company’s outstanding shares have now reached $287.14 million.
Considering the fact that the conglomerate employs 74000 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 45.22%, operating margin of 12.85%, and the pretax margin is 9.46%.
Becton Dickinson & Co (BDX) Insider Activity
Observing investor behavior towards Medical Instruments & Supplies industry stocks is more important than anything else. The insider ownership of Becton Dickinson & Co is 0.19%, while institutional ownership is 92.66%. The most recent insider transaction that took place on Mar 18 ’25, was worth 104,574. Before that another transaction happened on Mar 12 ’25, when Company’s EVP & President Interventional sold 1,940 for $224.91, making the entire transaction worth $436,325. This insider now owns 7,411 shares in total.
Becton Dickinson & Co (BDX) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 3.56 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 9.72% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.97% during the next five years compared to 8.27% growth over the previous five years of trading.
Becton Dickinson & Co (NYSE: BDX) Trading Performance Indicators
Becton Dickinson & Co (BDX) is currently performing well based on its current performance indicators. A quick ratio of 0.63 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.23. Likewise, its price to free cash flow for the trailing twelve months is 22.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 6.02, a number that is poised to hit 3.28 in the next quarter and is forecasted to reach 15.65 in one year’s time.
Technical Analysis of Becton Dickinson & Co (BDX)
Compared to the last year’s volume of 2.04 million, its volume of 2.14 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 49.89%. Additionally, its Average True Range was 4.71.
During the past 100 days, Becton Dickinson & Co’s (BDX) raw stochastic average was set at 40.07%, which indicates a significant decrease from 76.50% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 18.90% in the past 14 days, which was lower than the 21.49% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $232.60, while its 200-day Moving Average is $232.85. Nevertheless, the first resistance level for the watch stands at $234.46 in the near term. At $236.79, the stock is likely to face the second major resistance level. The third major resistance level sits at $240.82. If the price goes on to break the first support level at $228.10, it is likely to go to the next support level at $224.07. Should the price break the second support level, the third support level stands at $221.74.
Becton Dickinson & Co (NYSE: BDX) Key Stats
Market capitalization of the company is 66.65 billion based on 287,135K outstanding shares. Right now, sales total 20,178 M and income totals 1,705 M. The company made 5,168 M in profit during its latest quarter, and 303,000 K in sales during its previous quarter.
